Cancer Advances
Subscribe:
Featured Episode
Predicting Gastric Cancer Risk: A New EHR-Based Model
Chair of the Department of Gastroenterology, Hepatology and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss her team’s innovative work using electronic health records (EHR) to develop a predictive model for noncardia gastric cancer. Listen as Dr. Kim explains how the model uses common clinical variables to flag high-risk patients who may benefit from endoscopic screening.
Play NowAll Cancer Advances Episodes
May 15, 2025
Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)
Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.
Play NowMay 8, 2025
Evolving Care Models for Cancer Survivors
The Cancer Advances Podcast welcomes back Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, to explore the evolving landscape of survivorship care. Listen as Dr. Singh provides insights on how personalized, patient-centered approaches are being integrated with shared care models to address late effects, psychological challenges, and the needs of a growing population of cancer survivors.
Play NowMay 1, 2025
From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s
Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, joins the Cancer Advances Podcast to discuss a major new study exploring the link between GLP-1 receptor agonists and the risk of hematologic malignancies in patients with diabetes. Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for future cardio-oncology care.
Play NowApril 17, 2025
Rethinking Pediatric Hodgkin Lymphoma Care
The Cancer Advances Podcast is joined by the Chair of the Division of Pediatric Hematology Oncology and Director of the Bone Marrow Transplant Program, Rabi Hanna, MD, along with Ilia Buhtoiarov, MD, a physician at the Division of Pediatric Hematology Oncology leading the Leukemia Lymphoma Program to discuss evolving approaches to treating pediatric Hodgkin lymphoma. Listen as they talk about how novel therapies, including checkpoint inhibitors and PET-guided treatment strategies, are reshaping patient care and help avoid the need for bone marrow transplant.
Play Now
